P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

A. Esmail; J. Xu; G. Umoru; H. Al-Rawi; A. Saharia; M. Abdelrahim

doi:10.1016/j.annonc.2022.04.259

P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

A. Esmail, J. Xu, G. Umoru, H. Al-Rawi, A. Saharia, M. Abdelrahim

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S310
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.259
State	Published - 2022

Access to Document

10.1016/j.annonc.2022.04.259

https://www.sciencedirect.com/science/article/pii/S0923753422009498

Cite this

Esmail, A., Xu, J., Umoru, G., Al-Rawi, H., Saharia, A., & Abdelrahim, M. (2022). P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology, 33, S310. https://doi.org/10.1016/j.annonc.2022.04.259

P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. / Esmail, A.; Xu, J.; Umoru, G. et al.
In: Annals of Oncology, Vol. 33, 2022, p. S310.

Research output: Contribution to journal › Article › peer-review

Esmail, A, Xu, J, Umoru, G, Al-Rawi, H, Saharia, A & Abdelrahim, M 2022, 'P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022', Annals of Oncology, vol. 33, pp. S310. https://doi.org/10.1016/j.annonc.2022.04.259

Esmail A, Xu J, Umoru G, Al-Rawi H, Saharia A , Abdelrahim M. P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology. 2022;33:S310. doi: 10.1016/j.annonc.2022.04.259

@article{567fff13cb034d99be30ccb42fa48b15,

title = "P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022",

author = "A. Esmail and J. Xu and G. Umoru and H. Al-Rawi and A. Saharia and M. Abdelrahim",

year = "2022",

doi = "10.1016/j.annonc.2022.04.259",

language = "English (US)",

volume = "33",

pages = "S310",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - P-169 Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation

T2 - Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

AU - Esmail, A.

AU - Xu, J.

AU - Umoru, G.

AU - Al-Rawi, H.

AU - Saharia, A.

AU - Abdelrahim, M.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.04.259

DO - 10.1016/j.annonc.2022.04.259

M3 - Article

SN - 0923-7534

VL - 33

SP - S310

JO - Annals of Oncology

JF - Annals of Oncology

ER -